(VIANEWS) – Genmab (GMAB), ACM Research (ACMR), Atmos Energy Corporation (ATO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Genmab (GMAB)
36.9% sales growth and 21.17% return on equity
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and DuoHexaBody-CD37 for treating hematological malignancies. The company also develops Teclistamab, which is in Phase 2 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. In addition, it has approximately 20 active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with CureVac AG for the research and development of differentiated mRNA-based antibody products; argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, Novo Nordisk A/S, BliNK Biomedical SAS, and Bolt Biotherapeutics, Inc. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
Earnings Per Share
As for profitability, Genmab has a trailing twelve months EPS of $1.24.
PE Ratio
Genmab has a trailing twelve months price to earnings ratio of 30.1. Meaning, the purchaser of the share is investing $30.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.17%.
2. ACM Research (ACMR)
24% sales growth and 8.16% return on equity
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers with fine feature sizes; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.
Earnings Per Share
As for profitability, ACM Research has a trailing twelve months EPS of $0.76.
PE Ratio
ACM Research has a trailing twelve months price to earnings ratio of 17.07. Meaning, the purchaser of the share is investing $17.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.16%.
Moving Average
ACM Research’s value is way above its 50-day moving average of $11.44 and way higher than its 200-day moving average of $10.40.
Volume
Today’s last reported volume for ACM Research is 378756 which is 40.83% below its average volume of 640219.
Revenue Growth
Year-on-year quarterly revenue growth grew by 76%, now sitting on 420.9M for the twelve trailing months.
3. Atmos Energy Corporation (ATO)
23.4% sales growth and 8.65% return on equity
Atmos Energy Corporation, together with its subsidiaries, engages in the regulated natural gas distribution, and pipeline and storage businesses in the United States. It operates in two segments, Distribution, and Pipeline and Storage. The Distribution segment is involved in the regulated natural gas distribution and related sales operations in eight states. This segment distributes natural gas to approximately three million residential, commercial, public authority, and industrial customers. As of September 30, 2020, it owned 71,558 miles of underground distribution and transmission mains. The Pipeline and Storage segment engages in the pipeline and storage operations. This segment transports natural gas for third parties and manages five underground storage reservoirs in Texas; and provides ancillary services to the pipeline industry, including parking arrangements, lending, and inventory sales. As of September 30, 2020, it owned 5,684 miles of gas transmission lines. Atmos Energy Corporation was founded in 1906 and is headquartered in Dallas, Texas.
Earnings Per Share
As for profitability, Atmos Energy Corporation has a trailing twelve months EPS of $5.76.
PE Ratio
Atmos Energy Corporation has a trailing twelve months price to earnings ratio of 21.23. Meaning, the purchaser of the share is investing $21.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.65%.
4. NV5 Global (NVEE)
17.5% sales growth and 6.96% return on equity
NV5 Global, Inc. provides professional and technical engineering and consulting services to public and private sector clients in the infrastructure, utility services, construction, real estate, and environmental markets in the United States and internationally. It operates through three segments: Infrastructure; Building, Technology & Sciences; and Geospatial Solutions. The company offers site selection and planning, design, water resources, transportation, structural engineering, land development, surveying, power delivery, building code compliance, and other services; and construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting services. It also provides governmental outsourcing and consulting, and technical outsourcing services; and geospatial data analytic and mapping services. In addition, the company offers mechanical, electrical, and plumbing design; commissioning; energy performance, management, and optimization; building program management; acoustical design consulting; and audiovisual–security and surveillance–information technology–data center services, as well as energy services. Further, it provides various services, such as investigating and analyzing environmental conditions, and recommending corrective measures and procedures; occupational health and safety services; radiation exposure and protection, and nuclear safety and industrial hygiene analyses services; hydrogeological modeling and environmental programs; water resource planning, monitoring, and environmental management of wastewater facilities; solid waste landfill investigations; permitting and compliance; storm water pollution; environmental impact statement support; agricultural waste management and permitting; and wetland evaluations. The company was formerly known as NV5 Holdings, Inc. and changed its name to NV5 Global, Inc. in December 2015. NV5 Global, Inc. was founded in 1949 and is headquartered in Hollywood, Florida.
Earnings Per Share
As for profitability, NV5 Global has a trailing twelve months EPS of $3.07.
PE Ratio
NV5 Global has a trailing twelve months price to earnings ratio of 36.13. Meaning, the purchaser of the share is investing $36.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.96%.
Volume
Today’s last reported volume for NV5 Global is 2150 which is 97.89% below its average volume of 101895.
5. LSI Industries (LYTS)
11.1% sales growth and 14.52% return on equity
LSI Industries Inc. provides corporate visual image solutions in the United States, Canada, Mexico, Australia, and Latin America. It operates through Lighting and Graphics segments. The Lighting segment manufactures and markets outdoor and indoor lighting and lighting controls for parking lot and garage, quick-service restaurant, grocery and pharmacy store, automotive, and national retail markets. It primarily offers exterior area, interior, canopy, and landscape lightings, as well as lighting controls, light poles, and photometric layouts; lighting system design services; and solid-state LED solutions. This segment also designs, engineers, and manufactures electronic circuit boards, assemblies, and sub-assemblies. The Graphics segment manufactures and sells exterior and interior visual image elements used in graphics displays and visual image programs in various markets that include the petroleum/convenience store market, quick-service restaurant, grocery, and multi-site retail operations. Its products comprise signage and canopy graphics, pump dispenser graphics, building fascia graphics, decals, interior signage and marketing graphics, aisle markers, wall mural graphics, fleet graphics, video boards, menu boards, and digital signage and media content management products. This segment also provides installation management services for the installation of interior or exterior products. LSI Industries Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.
Earnings Per Share
As for profitability, LSI Industries has a trailing twelve months EPS of $0.79.
PE Ratio
LSI Industries has a trailing twelve months price to earnings ratio of 15.63. Meaning, the purchaser of the share is investing $15.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.52%.
6. OSI Systems (OSIS)
10.6% sales growth and 12.94% return on equity
OSI Systems, Inc. designs, manufactures, and sells electronic systems and components worldwide. It operates through three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, radiation detection, hold baggage and people screening, and explosive and narcotics trace detection systems under the Rapiscan Systems and AS&E names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.
Earnings Per Share
As for profitability, OSI Systems has a trailing twelve months EPS of $4.85.
PE Ratio
OSI Systems has a trailing twelve months price to earnings ratio of 24.93. Meaning, the purchaser of the share is investing $24.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.94%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
OSI Systems’s EBITDA is 59.69.
Volume
Today’s last reported volume for OSI Systems is 50337 which is 59.55% below its average volume of 124445.
